← Leaderboards
John R Yannelli
University Of Kentucky
$1,051,288
Attributed
$1,051,288
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $182K · FY2008–15$200K$150K$100K$50K$0
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,051,288 · 3
By mechanism
R01$543,339 · 1
R21$357,824 · 1
R03$150,125 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeUniversitiesInvestigationPeripheral Blood Mononuclear CellSourceTumor AntigensClinical ResearchImmunotherapyLaboratoriesNeoplastic CellResearch Clinical TestingSiteT-LymphocyteTumorCellsCell SurvivalDendritic CellsImmune ResponseIn VitroKentuckyMalignant NeoplasmsMethodologyReagentVaccines
Grant awards (6)
Evaluation of T Cell Response to Cisplatin Resistant NSCLC$75,125
R03 · FY2015 · CA · contact PI
Evaluation of T Cell Response to Cisplatin Resistant NSCLC$75,000
R03 · FY2014 · CA · contact PI
Cryopreparation of PBMC for Immunotherapy and Immune Assessment Studies.$182,024
R21 · FY2009 · CA · contact PI
Cryopreparation of PBMC for Immunotherapy and Immune Assessment Studies.$175,800
R21 · FY2008 · CA · contact PI
CTL DEFINED ANTIGENS IN NON SMALL CELL LUNG CANCER$271,407
R01 · FY2001 · CA
CTL DEFINED ANTIGENS IN NON SMALL CELL LUNG CANCER$271,932
R01 · FY2000 · CA